Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.

Mansour M, Haupt S, Chan AL, Godde N, Rizzitelli A, Loi S, Caramia F, Deb S, Takano EA, Bishton M, Johnstone C, Monahan B, Levav-Cohen Y, Jiang YH, Yap AS, Fox S, Bernard O, Anderson R, Haupt Y.

Cancer Res. 2019 Jun 1;79(11):3008. doi: 10.1158/0008-5472.CAN-19-1133. No abstract available.

PMID:
31160311
2.

Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.

Gamell C, Gulati T, Levav-Cohen Y, Young RJ, Do H, Pilling P, Takano E, Watkins N, Fox SB, Russell P, Ginsberg D, Monahan BJ, Wright G, Dobrovic A, Haupt S, Solomon B, Haupt Y.

Sci Signal. 2017 Jan 10;10(461). pii: eaaf8223. doi: 10.1126/scisignal.aaf8223.

PMID:
28074012
3.

The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.

Mansour M, Haupt S, Chan AL, Godde N, Rizzitelli A, Loi S, Caramia F, Deb S, Takano EA, Bishton M, Johnstone C, Monahan B, Levav-Cohen Y, Jiang YH, Yap AS, Fox S, Bernard O, Anderson R, Haupt Y.

Cancer Res. 2016 Jul 15;76(14):4236-48. doi: 10.1158/0008-5472.CAN-15-1553. Epub 2016 May 26. Retraction in: Cancer Res. 2019 Jun 1;79(11):3008.

4.

The p53-Mdm2 loop: a critical juncture of stress response.

Levav-Cohen Y, Goldberg Z, Tan KH, Alsheich-Bartok O, Zuckerman V, Haupt S, Haupt Y.

Subcell Biochem. 2014;85:161-86. doi: 10.1007/978-94-017-9211-0_9. Review.

PMID:
25201194
5.

The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress.

Wolyniec K, Levav-Cohen Y, Jiang YH, Haupt S, Haupt Y.

Oncogene. 2013 Jul 25;32(30):3510-9. doi: 10.1038/onc.2012.365. Epub 2012 Sep 17.

PMID:
22986523
6.

E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.

Wolyniec K, Shortt J, de Stanchina E, Levav-Cohen Y, Alsheich-Bartok O, Louria-Hayon I, Corneille V, Kumar B, Woods SJ, Opat S, Johnstone RW, Scott CL, Segal D, Pandolfi PP, Fox S, Strasser A, Jiang YH, Lowe SW, Haupt S, Haupt Y.

Blood. 2012 Jul 26;120(4):822-32. doi: 10.1182/blood-2011-10-387647. Epub 2012 Jun 11. Erratum in: Blood. 2014 Aug 14;124(7):1200.

7.

E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts.

Levav-Cohen Y, Wolyniec K, Alsheich-Bartok O, Chan AL, Woods SJ, Jiang YH, Haupt S, Haupt Y.

Oncogene. 2012 Apr 26;31(17):2199-209. doi: 10.1038/onc.2011.402. Epub 2011 Sep 19.

PMID:
21927031
8.

HPV16 E6 augments Wnt signaling in an E6AP-dependent manner.

Lichtig H, Gilboa DA, Jackman A, Gonen P, Levav-Cohen Y, Haupt Y, Sherman L.

Virology. 2010 Jan 5;396(1):47-58. doi: 10.1016/j.virol.2009.10.011. Epub 2009 Nov 6.

9.

E6AP promotes the degradation of the PML tumor suppressor.

Louria-Hayon I, Alsheich-Bartok O, Levav-Cohen Y, Silberman I, Berger M, Grossman T, Matentzoglu K, Jiang YH, Muller S, Scheffner M, Haupt S, Haupt Y.

Cell Death Differ. 2009 Aug;16(8):1156-66. doi: 10.1038/cdd.2009.31. Epub 2009 Mar 27.

10.

Mdm2 in growth signaling and cancer.

Levav-Cohen Y, Haupt S, Haupt Y.

Growth Factors. 2005 Sep;23(3):183-92. Review.

PMID:
16243710
11.

C-Abl as a modulator of p53.

Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. Review.

PMID:
15865930

Supplemental Content

Loading ...
Support Center